The emerging approach of the medication represents a major breakthrough in the handling of type 2 diabetes. Unlike existing therapies, tirzepatide affects multiple pathways – GLP-1 and GIP – resulting in improved https://tirzepatide-peptide826796.blogdemls.com/41758092/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment